Elimusertib, a Novel ATR Inhibitor, Induces Anti-Tumor Effects through Replication Catastrophe in Breast Cancers [0.03%]
新型ATR抑制剂依来美斯替布通过复制灾难效应诱导乳腺癌的抗肿瘤作用
Mudong Kim,Ahrum Min,Sohyeon Kim et al.
Mudong Kim et al.
Purpose: Sustained cell proliferation and cell cycle acceleration in cancer cells inherently increase DNA damage, which interferes with homeostatic replication and transcription. Ataxia telangiectasia and Rad3-related (AT...
Reduced Dose and Selective Neck Irradiation Policy in Treating Oropharynx Cancer: Excellent Oncological Outcomes with very Low Risk of Locoregional Failure [0.03%]
降低剂量和选择性颈部分野照射治疗咽癌的疗效分析：极低局部区域复发率伴良好肿瘤学效果
Eunyeong Yang,Seung Gyu Park,Kyungmi Yang et al.
Eunyeong Yang et al.
Purpose: To evaluate the risk of locoregional failure after reduced dose selective neck irradiation (RD-SNI) in patients with oropharyngeal cancer (OPC). ...
Exploring Oncologists' Perspectives on the Early Integration of Specialty Palliative Care in Korea: Challenges, Needs, and Clinical Implications [0.03%]
探索韩国肿瘤学家对早期整合专科姑息治疗的观点：挑战、需求和临床意义
Shin Hye Yoo,Yu Jung Kim,Ye Sul Jeung et al.
Shin Hye Yoo et al.
Purpose: This study aimed to explore the practices, perceptions, and barriers related to specialty palliative care (SPC) referrals among oncologists in Korea, highlighting the clinical implications of early integration. ...
The Effect of Alcohol Consumption Behavior Changes on Gastric Cancer Risks Stratified by Sex in South Korea [0.03%]
分性别分析饮酒行为变化对韩国胃癌风险的影响
Yonghoon Choi,Jieun Jang,Hyeong Ho Jo et al.
Yonghoon Choi et al.
Purpose: The effect of behavior changes in alcohol drinking on gastric cancer (GC) development, and the sex differences in those effects have not yet been fully elucidated. This study investigated the effect of behavior c...
Presentation of Benefits and Harms in Cancer Screening Guidelines for Koreans: A Systematic Review [0.03%]
韩国癌症筛查指南中益处和危害的呈现情况：系统综述
Mi Ah Han,Hunju Lee,Kwangmin Kim et al.
Mi Ah Han et al.
Purpose: This study systematically reviewed cancer screening guidelines for the Korean population to evaluate the benefits and harms of the recommended cancer screening practices. ...
The Role of Circulating Tumor Cell as a Promising Biomarker in the Evaluation of Pulmonary Nodules: A Prospective Study [0.03%]
循环肿瘤细胞作为评估肺结节的理想生物标志物的作用：一项前瞻性研究
Shijie Wang,Changdan Xu,Xiaohong Xu et al.
Shijie Wang et al.
Purpose: Our previous study showed that circulating tumor cell (CTC) count combined with gene mutation detection might help differentiate benign and malignant pulmonary nodules (PNs). Herein, we aimed to expand the study ...
Association of Physical Activity with Dementia Risk in Cancer Survivors: A Korean Nationwide Cohort Study [0.03%]
体力活动与癌症幸存者痴呆风险的关联：一项韩国全国队列研究
Su Kyoung Lee,Minji Han,Sangwoo Park et al.
Su Kyoung Lee et al.
Purpose: This study aimed to investigate the impact of physical activity on dementia risk among cancer survivors in South Korea. Materials and methods: ...
Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian Cancer [0.03%]
既往接受PARP抑制剂治疗后再接受化疗在卵巢癌患者中疗效的研究
Jung Chul Kim,Junsik Park,Yong Jae Lee et al.
Jung Chul Kim et al.
Purpose: Considering the current lack of consensus on post-poly (adenosine diphosphate-ribose) polymerase inhibitor (PARPi) treatment strategies, this study aimed to evaluate the efficacy of subsequent therapy and compare...
Elevated SLC3A2 Expression Promotes the Progression of Gliomas and Enhances Ferroptosis Resistance through the AKT/NRF2/GPX4 Axis [0.03%]
SLC3A2的高表达通过AKT/NRF2/GPX4轴促进胶质瘤进展并增强铁死亡抵抗能力
Yuqian Zheng,Shaolong Zhou,Yiran Tao et al.
Yuqian Zheng et al.
Purpose: The aim of this study is to determine the impact of SLC3A2 on the malignant phenotype of gliomas and its role in regulating ferroptosis sensitivity. ...
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2022 [0.03%]
韩国的癌症统计数据：2022年的发病率、死亡率、生存率和患病率
Eun Hye Park,Kyu-Won Jung,Nam Ju Park et al.
Eun Hye Park et al.
Purpose: The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2022, with international comparisons. ...